Pulmonary and vascular pharmacology of sphingosine 1-phosphate

被引:62
作者
Brinkmann, Volker
Baumruker, Thomas
机构
[1] Novartis, Biomed Res Inst, Autoimmun & Transplantat, CH-4002 Basel, Switzerland
[2] Novartis Inst BioMed Res, Autoimmun & Transplantat, A-1235 Vienna, Austria
关键词
D O I
10.1016/j.coph.2005.12.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dysregulation of vasomotor tone, endothelial barrier function and imnune cell trafficking are central to the pathology of many lung diseases, including acute lung injury, adult respiratory distress syndrome, chronic obstructive pulmonary disease and asthma There is increasing evidence that the serum sphingolipid sphingosine 1-phosphate and its G-protein-coupled receptors are pivotal not only in the regulation of lymphocyte migration, but also in the maintenance of vascular homeostasis and the preservation of permeability barriers that separate discrete compartments in the lung.
引用
收藏
页码:244 / 250
页数:7
相关论文
共 56 条
[1]   G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation [J].
Allende, ML ;
Yamashita, T ;
Proia, RL .
BLOOD, 2003, 102 (10) :3665-3667
[2]   Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma [J].
Ammit, AJ ;
Hastie, AT ;
Edsall, LC ;
Hoffman, RK ;
Amrani, Y ;
Krymskaya, VP ;
Kane, SA ;
Peters, SP ;
Penn, RB ;
Spiegel, S ;
Panettieri, RA .
FASEB JOURNAL, 2001, 15 (07) :1212-1214
[3]   Extracellular export of sphingosine kinase-1 enzyme - Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation [J].
Ancellin, N ;
Colmont, C ;
Su, J ;
Li, Q ;
Mittereder, N ;
Chae, SS ;
Stefansson, S ;
Liau, G ;
Hla, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6667-6675
[4]   Cell surface receptors in lysophospholipid signaling [J].
Anliker, B ;
Chun, J .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (05) :457-465
[5]   Sphingolipids and the regulation of the immune response [J].
Baumruker, T ;
Prieschl, EE .
SEMINARS IN IMMUNOLOGY, 2002, 14 (01) :57-63
[6]   The immune modulator FTY720 targets sphingosine 1-phosphate receptors [J].
Brinkmann, V ;
Davis, MD ;
Heise, CE ;
Albert, R ;
Cottens, S ;
Hof, R ;
Bruns, C ;
Prieschl, E ;
Baumruker, T ;
Hiestand, P ;
Foster, CA ;
Zollinger, M ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21453-21457
[7]   FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function [J].
Brinkmann, V ;
Cyster, JG ;
Hla, T .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) :1019-1025
[8]   FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity [J].
Brinkmann, V ;
Lynch, KR .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (05) :569-575
[9]   FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation [J].
Brinkmann, V ;
Pinschewer, D ;
Chiba, K ;
Feng, LL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) :49-52
[10]   Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling [J].
Chalfant, CE ;
Spiegel, S .
JOURNAL OF CELL SCIENCE, 2005, 118 (20) :4605-4612